MedTrace Logo

Symptom-limited Stair Climbing Test in Heart Failure

NCT04352426 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2020-04-20

No results posted yet for this study

Summary

Aims: To assess the efficacy of symptom-limited stair-climbing test (SLSCT), in determining the exercise capacities of patients with chronic heart failure (CHF) in comparison with cardiopulmonary exercise test (CPET) and 6-minute walk test(6MWT) and to interpret the results according to the clinical status of the patients.

Methods: Thirty-one patients, aged 50-75 years, with stage II-III CHF according to the New York Heart Association Classification and left ventricular ejection fraction (LVEF) of ≤45% were included. The demographic and clinical characteristics of the patients were recorded. Exercise capacity was assessed by SLSCT, 6MWT, and CPET. The duration of patients' performance in the test, reasons for ending the test and predicted maximal oxygen consumption (VO2max) were recorded. Heart rate (HR), blood pressure (BP), dyspnoea severity \[Modified Borg Scale (MBS)\] and peripheral oxygen saturation were recorded. Pulmonary functions were assessed by spirometry.

Conditions

Interventions

OTHER

Exercise Test

Tests were conducted to evaluate exercise capacity.

Sponsors & Collaborators

  • KTO Karatay University

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-13
Primary Completion
2017-11-10
Completion
2017-11-12

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04352426 on ClinicalTrials.gov